Adicet Bio, Inc. SEC filings ACET

Adicet Bio, Inc. has 682 filings in SEC EDGAR's recent list, going back to Oct 27, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 26.

Form Description Filed Period
10-K/A Amended annual report May 20, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 6, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
10-K Annual report Mar 19, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K/A Amended annual report Aug 16, 2021 Dec 31, 2020
10-K Annual report Mar 12, 2021 Dec 31, 2020
10-K Annual report Mar 12, 2020 Dec 31, 2019
10-K Annual report Mar 18, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 27, 2018 Dec 31, 2017
10-K Annual report Mar 29, 2018 Dec 31, 2017

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACET (Nasdaq)
Fiscal year ends
December 26
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1720580
Former names
resTORbio, Inc. (until Aug 21, 2020)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.